相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
Maria Auxiliadora Olivares-Urbano et al.
CELLS (2020)
Cancer Stem Cells,Quo Vadis? The Notch Signaling Pathway in Tumor Initiation and Progression
Christian T. Meisel et al.
CELLS (2020)
Radiotherapy targeting cancer stem cells awakens them to induce tumour relapse and metastasis in oral cancer
Yangfan Liu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
PI3K/Akt/mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
Arunaksharan Narayanankutty
CURRENT DRUG TARGETS (2019)
Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer
Ji-Hye Park et al.
CANCER SCIENCE (2019)
Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment
Sabine Francois et al.
STEM CELLS TRANSLATIONAL MEDICINE (2019)
Cancer stem cells in colorectal cancer: a review
Matthew J. Munro et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Sox2 is associated with cancer stem-like properties in colorectal cancer
Koki Takeda et al.
SCIENTIFIC REPORTS (2018)
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation
Su Yeon Lee et al.
MOLECULAR CANCER (2017)
RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer
Ke Hui et al.
CELL DEATH & DISEASE (2017)
Therapeutic strategies against cancer stem cells in human colorectal cancer
Magdalena Szarynska et al.
ONCOLOGY LETTERS (2017)
SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer
Fengyu Zhu et al.
STEM CELL REPORTS (2017)
MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma
Scott Haston et al.
DEVELOPMENT (2017)
SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer
Ida V. Lundberg et al.
BMC CANCER (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression
Min-Hyung Cho et al.
NATURE COMMUNICATIONS (2015)
Molecular and functional interactions between AKT and SOX2 in breast carcinoma
Thorsten Schaefer et al.
ONCOTARGET (2015)
DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2
Juan Qin et al.
ONCOTARGET (2015)
EMT, CTCs and CSCs in tumor relapse and drug-resistance
Abhisek Mitra et al.
ONCOTARGET (2015)
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
Ann Zeuner et al.
CELL STEM CELL (2014)
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Soufiane Boumahdi et al.
NATURE (2014)
Cervical Cancer Cells with Positive Sox2 Expression Exhibit the Properties of Cancer Stem Cells
Xiao-Fang Liu et al.
PLOS ONE (2014)
SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells
M. Herreros-Villanueva et al.
ONCOGENESIS (2013)
The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells
Miyuki Shimoda et al.
BMC CANCER (2012)
EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
Thomas Brabletz
CANCER CELL (2012)
Ionizing Radiation Induces Stemness in Cancer Cells
Laura Ghisolfi et al.
PLOS ONE (2012)
Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients
Xu Han et al.
PLOS ONE (2012)
Expression of CD133 correlates with differentiation of human colon cancer cells.
Hai-Liang Feng et al.
CANCER BIOLOGY & THERAPY (2010)
Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+primary colon cancer cells
Y. K. Wang et al.
CARCINOGENESIS (2010)
All purpose Sox: The many roles of Sox proteins in gene expression
Michael Wegner
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Sex determination and SRY: down to a wink and a nudge?
Ryohei Sekido et al.
TRENDS IN GENETICS (2009)
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Lei Du et al.
CLINICAL CANCER RESEARCH (2008)
CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors
Sergey V. Shmelkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
c-Src-p38 Mitogen-Activated Protein Kinase Signaling Is Required for Akt Activation in Response to Ionizing Radiation
Min-Jung Kim et al.
MOLECULAR CANCER RESEARCH (2008)
Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging
Davide Vigetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion
CH Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Mechanism and biological significance of CD44 cleavage
O Nagano et al.
CANCER SCIENCE (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
分享论文
